{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T12:34:59Z","timestamp":1778934899502,"version":"3.51.4"},"reference-count":19,"publisher":"Medknow","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Saudi J Kidney Dis Transpl"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/1319-2442.284031","type":"journal-article","created":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T08:54:12Z","timestamp":1589014452000},"page":"528","source":"Crossref","is-referenced-by-count":3,"title":["Mesalazine induced focal segmental glomerulosclerosis in a patient with ulcerative colitis"],"prefix":"10.4103","volume":"31","author":[{"given":"Fatih","family":"Yilmaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bora","family":"Uslu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahar","family":"Akkaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramazan","family":"Cetinkaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2581","reference":[{"key":"key-10.4103\/1319-2442.284031-1","doi-asserted-by":"crossref","unstructured":"De Broe ME, Stolear JC, Nouwen EJ, Elseviers MM. 5-Aminosalicylic acid (5-ASA) and chronic tubulointerstitial nephritis in patients with chronic inflammatory bowel disease: is there a link? Nephrol Dial Transplant 1997;12:1839","DOI":"10.1093\/ndt\/12.9.1839"},{"key":"key-10.4103\/1319-2442.284031-2","doi-asserted-by":"crossref","unstructured":"Siveke JT, Egert J, Sitter T, et al. 5-ASA therapy and renal function in inflamatory bowel disease. Am J Gastroenterol 2005; 100:501","DOI":"10.1111\/j.1572-0241.2005.t01-5-41219.x"},{"key":"key-10.4103\/1319-2442.284031-3","doi-asserted-by":"crossref","unstructured":"Novis BH, Korzets Z, Chen P, Bernheim J. Nephrotic syndrome after treatment with 5- aminosalicylic acid. Br Med J (Clin Res Ed) 1988;296:1442","DOI":"10.1136\/bmj.296.6634.1442"},{"key":"key-10.4103\/1319-2442.284031-4","doi-asserted-by":"crossref","unstructured":"Fornaciari G, Maccari S, Borgatti PP, et al. Nephrotic syndrome from 5-ASA for ulcerative colitis? Complicated by carcinoma of the colon and sclerosing cholangitis. J Clin Gastroenterol 1997;24:37-9","DOI":"10.1097\/00004836-199701000-00008"},{"key":"key-10.4103\/1319-2442.284031-5","doi-asserted-by":"crossref","unstructured":"Skhiri H, Knebelmann B, Martin-Lefevre L, Grunfeld JP. Nephrotic syndrome associated with inflammatory bowel disease treated by mesalazine. Nephron 1998;79:236","DOI":"10.1159\/000045038"},{"key":"key-10.4103\/1319-2442.284031-6","doi-asserted-by":"crossref","unstructured":"Firwana BM, Hasan R, Chalhoub W, et al. Nephrotic syndrome after treatment of Crohn\u2019s disease with mesalamine: Case report and literature review. Avicenna J Med 2012;2:9- 11","DOI":"10.4103\/2231-0770.94804"},{"key":"key-10.4103\/1319-2442.284031-7","doi-asserted-by":"crossref","unstructured":"Schell C, Huber TB. New players in the pathogenesis of focal segmental glomerulo- sclerosis. Nephrol Dial Transplant 2012;27: 3406-12","DOI":"10.1093\/ndt\/gfs273"},{"key":"key-10.4103\/1319-2442.284031-8","doi-asserted-by":"crossref","unstructured":"D\u2019Agati VD, Kaskel FJ, Falk RJ. Focal segmental glomerulosclerosis. N Engl J Med 2011;365:2398-411","DOI":"10.1056\/NEJMra1106556"},{"key":"key-10.4103\/1319-2442.284031-9","unstructured":"Fofi C, Nicoletti MC, Onetti Muda A, Giulio S. Focal segmental glomerulosclerosis with IgA deposits in a patient with ulcerative colitis. G Ital Nefrol 2003;20:641-4"},{"key":"key-10.4103\/1319-2442.284031-10","doi-asserted-by":"crossref","unstructured":"Chirumamilla SR, He C, Racusen LC, Scheimann AO, Cuffari C. Acute kidney injury in a girl with ulcerative colitis and cytomegalo- virus induced focal segmental glomerular sclerosis. World J Pediatr 2013;9:84-6","DOI":"10.1007\/s12519-011-0302-8"},{"key":"key-10.4103\/1319-2442.284031-11","doi-asserted-by":"crossref","unstructured":"Corrigan G, Stevens PE. Review article: interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease. Aliment Pharmacol Ther 2000;14:1-6","DOI":"10.1046\/j.1365-2036.2000.00683.x"},{"key":"key-10.4103\/1319-2442.284031-12","unstructured":"Tekin F, Ozutemiz O, Ilter T. Acute tubulo- interstitial nephritis due to 5-aminosalicylic acid in a patient with ulcerative colitis and chronic renal failure. Turk J Gastroenterol 2006;17:153-4"},{"key":"key-10.4103\/1319-2442.284031-13","doi-asserted-by":"crossref","unstructured":"Van Staa TP, Travis S, Leufkens HG, Logan RF. 5-aminosalicylic acids and the risk of renal disease: A large British epidemiologic study. Gastroenterology 2004;126:1733-9","DOI":"10.1053\/j.gastro.2004.03.016"},{"key":"key-10.4103\/1319-2442.284031-14","doi-asserted-by":"crossref","unstructured":"Fraser JS, Muller AF, Smith DJ, Newman DJ, Lamb EJ. Renal tubular injury is present in acute inflammatory bowel disease prior to the introduction of drug therapy. Aliment Pharmacol Ther 2001;15:1131-7","DOI":"10.1046\/j.1365-2036.2001.01041.x"},{"key":"key-10.4103\/1319-2442.284031-15","doi-asserted-by":"crossref","unstructured":"Gisbert JP, Gonzalez-Lama Y, Mate J. 5- Aminosalicylates and renal function in inflammatory bowel disease: A systematic review. Inflamm Bowel Dis 2007;13:629-38","DOI":"10.1002\/ibd.20099"},{"key":"key-10.4103\/1319-2442.284031-16","doi-asserted-by":"crossref","unstructured":"Elseviers MM, D\u2019Haens G, Lerebours E, et al. Renal impairment in patients with inflammatory bowel disease: Association with aminosalicylate therapy? Clin Nephrol 2004; 61:83-9","DOI":"10.5414\/CNP61083"},{"key":"key-10.4103\/1319-2442.284031-17","doi-asserted-by":"crossref","unstructured":"Sameshima S, Koketsu S, Okuyama T, et al. Ulcerative colitis associated with nephrotic syndrome after treatment with mesalazine developed into rectal carcinoma: A case study. World J Surg Oncol 2016;14:192","DOI":"10.1186\/s12957-016-0950-1"},{"key":"key-10.4103\/1319-2442.284031-18","unstructured":"The KDIGO practice guideline on glomerulonephritis. Kidney Int Suppl 2012;2:143-53"},{"key":"key-10.4103\/1319-2442.284031-19","first-page":"E798","volume-title":"Nephrotic syndrome and Moya-moya syndrome in a patient with ulcerative colitis","author":"Xinmei","year":"2012","journal-title":"Inflamm Bowel Dis"}],"container-title":["Saudi Journal of Kidney Diseases and Transplantation"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T09:04:35Z","timestamp":1589015075000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.sjkdt.org\/text.asp?2020\/31\/2\/528\/284031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"alternative-id":["284031"],"URL":"https:\/\/doi.org\/10.4103\/1319-2442.284031","relation":{},"ISSN":["1319-2442"],"issn-type":[{"value":"1319-2442","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}